Pfizer Inc. (PFE)
After hours:
| Previous Close | 26.26 |
| Open | 26.33 |
| Bid | 26.31 x 3100 |
| Ask | 26.32 x 2200 |
| Day's Range | 26.19 - 26.47 |
| 52 Week Range | 25.23 - 40.37 |
| Volume | |
| Avg. Volume | 42,881,541 |
| Market Cap | 149.038B |
| Beta (5Y Monthly) | 0.57 |
| PE Ratio (TTM) | 71.14 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.68 (6.40%) |
| Ex-Dividend Date | Jan 25, 2024 |
| 1y Target Est | N/A |
- Reuters
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.
- Zacks
Pfizer (PFE) Rises Higher Than Market: Key Facts
Pfizer (PFE) reachead $26.26 at the closing of the latest trading day, reflecting a +1% change compared to its last close.
- Insider Monkey
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
